FORTUNE
by Grady McGregor / Jul 14, 2022 / 4:04 AM
For now, Novavax’s vaccine will only be available in the U.S. as a primary, two-dose regimen, meaning those who want a Novavax booster shot will likely have to wait several weeks or longer.
Novavax’s vaccine has been approved as both a primary vaccine and a booster in dozens of markets including in the European Union, Australia, and Japan. The company will soon seek authorization as a booster dose in the U.S. and is working on an Omicron-specific booster jab that it expects to roll out later this fall.
On July 1, Novavax said that its vaccine prompted “broad immune responses” against all COVID variants, including BA.5, in clinical data. Novavax has not publicly released the data, but some experts are optimistic that it might outperform mRNA vaccines against BA.5 due to its technology.
